Gain Therapeutics logo
Gain Therapeutics
GANX | NASDAQ
Chart Builder DCF Calculator
$0.94
-$0.10 (-9.62%)
At close: Nov 16, 2026, 4:00 PM ET
$1.10
+$0.16 (+17.02%)
After-hours: Nov 16, 2026, 6:40 PM ET

Gain Therapeutics Institutional Ownership

Institutional ownership explained

Institutional Ownership

Net Inflow
Dollar & Volume Weighted
Total Institutions
54
Total Ownership
20.20%
Capital Flow
+$1.57M
Shares Change
+465.78K
Ownership Distribution
Institutions (20.20%)
Others (79.80%)

Institutional Sentiment

Overall: bullish
Equity Sentiment & Activity
bullish
New Positions
12
Increased Positions
26
Reduced Positions
9
Closed Positions
4
New (12)
Increased (26)
Reduced (9)
Closed (4)
Options Sentiment & Activity
bullish
Put/Call Ratio
0.321
Call Flow
111,200
Put Flow
35,700
Calls (76%)
Puts (24%)

Super Investors

Super Investor / Fund Ownership Portfolio Weight Shares Market Value
Greenlight Capital Inc
1.37%
0.00%
0.04%
588.41K
1.06M

Top Shareholders

Institution Ownership Portfolio Weight Shares Market Value
Marshall Wace, Llp
4.49%
+7.04%
< 0.01%
-9.87%
1.92M
+8.69%
3.9M
+13.73%
Potomac Capital Management, Inc.
2.21%
-7.59%
1.31%
-22.95%
946.4K
-6.17%
1.92M
-1.81%
Gsa Capital Partners Llp
1.47%
+99.24%
0.08%
+114.72%
632.13K
+102.30%
1.28M
+111.72%
Pro Membership

Stop Guessing, Start Knowing.

Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.

Unlimited access

Unlimited access to all data and tools, giving you the edge over everyone else in the market.

Proprietary Stock Rating Score

Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.

Top Wall Street Analyst Ratings

Follow ratings from the best analysts on Wall Street to stay ahead of market moves.

Up to 30 years financial history

We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.